Finn SP - Search Results

1

Biodistribution and histological analysis of iron oxide-dextran nanoparticles in wistar rats.

Hannon G, Bogdanska A, Keogh A, Finn SP, Gobbo OL, Prina-Mello A. Hannon G, et al. Among authors: finn sp. Nanotoxicology. 2023 Dec;17(8-9):562-580. doi: 10.1080/17435390.2023.2276413. Epub 2023 Dec 14. Nanotoxicology. 2023. PMID: 37982374

2

Multiplex profiling identifies clinically relevant signalling proteins in an isogenic prostate cancer model of radioresistance.

Inder S, Bates M, Ni Labhrai N, McDermott N, Schneider J, Erdmann G, Jamerson T, Belle VA, Prina-Mello A, Thirion P, Manecksha PR, Cormican D, Finn S, Lynch T, Marignol L. Inder S, et al. Sci Rep. 2019 Nov 22;9(1):17325. doi: 10.1038/s41598-019-53799-7. Sci Rep. 2019. PMID: 31758038 Free PMC article.

3

Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer.

Keogh A, Finn S, Radonic T. Keogh A, et al. Cancers (Basel). 2022 Aug 3;14(15):3772. doi: 10.3390/cancers14153772. Cancers (Basel). 2022. PMID: 35954436 Free PMC article. Review.

4

Lung Cancer in the Republic of Ireland.

Keogh RJ, Barr MP, Keogh A, McMahon D, Baird AM, Cotter S, Breen D, Fitzmaurice GJ, Fitzpatrick D, O'Brien C, Finn SP, Naidoo J. Keogh RJ, et al. Among authors: finn sp. J Thorac Oncol. 2023 Jul;18(7):851-857. doi: 10.1016/j.jtho.2023.03.027. J Thorac Oncol. 2023. PMID: 37348994 Free article. No abstract available.

5

An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC).

Murphy C, Gornés Pons G, Keogh A, Ryan L, McCarra L, Jose CM, Kesar S, Nicholson S, Fitzmaurice GJ, Ryan R, Young V, Cuffe S, Finn SP, Gray SG. Murphy C, et al. Among authors: finn sp. Biomedicines. 2023 Sep 19;11(9):2576. doi: 10.3390/biomedicines11092576. Biomedicines. 2023. PMID: 37761019 Free PMC article.

6

Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.

Oner E, Kotmakci M, Baird AM, Gray SG, Debelec Butuner B, Bozkurt E, Kantarci AG, Finn SP. Oner E, et al. Among authors: finn sp. J Nanobiotechnology. 2021 Mar 8;19(1):71. doi: 10.1186/s12951-021-00781-z. J Nanobiotechnology. 2021. PMID: 33685469 Free PMC article.

7

Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma.

Murchan P, Baird AM, Ó Broin P, Sheils O, Finn SP. Murchan P, et al. Among authors: finn sp. Diagnostics (Basel). 2024 Feb 20;14(5):462. doi: 10.3390/diagnostics14050462. Diagnostics (Basel). 2024. PMID: 38472935 Free PMC article.

8

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer.

M Saini V, Oner E, Ward MP, Hurley S, Henderson BD, Lewis F, Finn SP, Fitzmaurice GJ, O'Leary JJ, O'Toole S, O'Driscoll L, Gately K. M Saini V, et al. Among authors: finn sp. Mol Oncol. 2024 Aug 6. doi: 10.1002/1878-0261.13705. Online ahead of print. Mol Oncol. 2024. PMID: 39105395 Free article.

9

Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer.

McNevin CS, Baird AM, McDermott R, Finn SP. McNevin CS, et al. Among authors: finn sp. Diagnostics (Basel). 2021 Feb 19;11(2):345. doi: 10.3390/diagnostics11020345. Diagnostics (Basel). 2021. PMID: 33669657 Free PMC article. Review.

10

Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer.

Brady L, Carlsson J, Baird AM, Casey O, Vlajnic T, Murchan P, Cormican D, Costigan D, Gray S, Sheils O, O'Neill A, Watson RW, Andren O, Finn S. Brady L, et al. Cancer Treat Res Commun. 2021;29:100451. doi: 10.1016/j.ctarc.2021.100451. Epub 2021 Sep 2. Cancer Treat Res Commun. 2021. PMID: 34507017 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters